financetom
Business
financetom
/
Business
/
Hillman Solutions Reprices $643 Million Term Loan Due 2028
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hillman Solutions Reprices $643 Million Term Loan Due 2028
Jan 15, 2025 7:58 AM

10:20 AM EST, 01/15/2025 (MT Newswires) -- Hillman Solutions ( HLMN ) said Wednesday it repriced its existing $643 million term loan due July 14, 2028, lowering its interest rate margin by 25 basis points to a secured overnight financing rate plus 200 basis points.

The company projects annualized interest savings at roughly $1.6 million, before about $1 million one-time fees.

Hillman shares were up 2% in recent trading.

Price: 10.09, Change: +0.21, Percent Change: +2.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cabaletta Bio Gets Orphan Drug Designation From FDA For Systemic Sclerosis Treatment
Cabaletta Bio Gets Orphan Drug Designation From FDA For Systemic Sclerosis Treatment
Mar 20, 2024
10:57 AM EDT, 03/20/2024 (MT Newswires) -- Cabaletta Bio ( CABA ) said Wednesday the US Food and Drug Administration has given orphan drug designation to CABA-201 to potentially treat systemic sclerosis. The candidate drug is being developed to treat autoimmune diseases driven by B cells, the company said, adding the clinical trial program has four phase 1/2 trials to...
New Fortress Energy Closes on Purchase of Electricity Supply Contract in Brazil
New Fortress Energy Closes on Purchase of Electricity Supply Contract in Brazil
Mar 20, 2024
11:00 AM EDT, 03/20/2024 (MT Newswires) -- New Fortress Energy ( NFE ) said Wednesday it has completed its acquisition of a 1.6-gigawatt capacity reserve electricity contract from a portfolio company of private equity firm Denham Capital. Under terms of the purchase agreement, New Fortress will issue a undisclosed amount of its series A convertible preferred stock to Denham Capital...
Celularity Seeks FDA Orphan Drug Status for PDA-002 in Facioscapulohumeral Muscular Dystrophy
Celularity Seeks FDA Orphan Drug Status for PDA-002 in Facioscapulohumeral Muscular Dystrophy
Mar 20, 2024
11:01 AM EDT, 03/20/2024 (MT Newswires) -- Celularity ( CELU ) said Wednesday it submitted an application to the US Food and Drug Administration requesting an orphan drug designation for PDA-002 as a treatment for genetic muscle disorder facioscapulohumeral muscular dystrophy. The FDA has already approved the investigative new drug application for PDA-002 and Celularity ( CELU ) will start...
AAR Signs Multiyear Deal to Supply CFM56-5B Engine Surplus Material to Cebu Pacific
AAR Signs Multiyear Deal to Supply CFM56-5B Engine Surplus Material to Cebu Pacific
Mar 20, 2024
10:59 AM EDT, 03/20/2024 (MT Newswires) -- AAR (AIR) said Wednesday it has a multiyear agreement to provide surplus material for the CFM56-5B engine to Cebu Pacific. Financial details weren't disclosed. Under the accord, AAR said it will assist with the 30 scheduled shop visits for CFM56-5B engines that Cebu Pacific has scheduled throughout the contract period. Shares of ARR...
Copyright 2023-2026 - www.financetom.com All Rights Reserved